Nanomedicine enables efficient CRISPR-Cas9 genome editing for disease treatment.
Science bulletin, 67(6): 572-576 PMID 36546116 DOI 10.1016/j.scib.2021.11.016
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.